This trial is testing whether it's safe to use human umbilical vein cells to help heal anal fistulas.
- Anal Fistulas
1 Primary · 4 Secondary · Reporting Duration: 6, 24 weeks after surgery
2 Treatment Groups
Cell Therapy Treatment Part B
1 of 2
Cell Therapy Treatment
1 of 2
12 Total Participants · 2 Treatment Groups
Primary Treatment: E-CEL UVEC · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
To what extent is this study populated with participants?
"Affirmative, based on the information hosted by clinicaltrials.gov this medical study is currently recruiting. It was originally published on January 22nd 2020 and most recently edited April 29th 2022. They are looking for 12 individuals to enroll in their experiment at one centre." - Anonymous Online Contributor
What implications does E-CEL UVEC pose for the health of individuals?
"Our team at Power assessed E-CEL UVEC's safety as a 1 due to the limited data on both its efficacy and security, characteristic of Phase 1 trials." - Anonymous Online Contributor
Is enrollment for this research project still open?
"According to clinicialtrials.gov, this research is actively recruiting for new participants as of 4/29/2022. It was initially posted on 1/22/2020." - Anonymous Online Contributor